Cargando…

Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus

Type 2 diabetes mellitus (T2DM) is associated with skeletal complications, including an increased risk of fractures. Reduced blood supply and bone strength may contribute to this skeletal fragility. We hypothesized that long-term administration of Exenatide, a glucagon-like peptide-1 receptor agonis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pereira, Marie, Gohin, Stephanie, Roux, Jean-Paul, Fisher, Amy, Cleasby, Mark E., Mabilleau, Guillaume, Chenu, Chantal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701968/ https://www.ncbi.nlm.nih.gov/pubmed/29209277 http://dx.doi.org/10.3389/fendo.2017.00327

Ejemplares similares

The GLP-1 Receptor Agonist Exenatide Ameliorates Bone Composition and Tissue Material Properties in High Fat Fed Diabetic Mice
por: Mansur, Sity Aishah, et al.
Publicado: (2019)

Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus
por: Pereira, M., et al.
Publicado: (2016)

[Gly²]-GLP-2, But Not Glucagon or [D-Ala²]-GLP-1, Controls Collagen Crosslinking in Murine Osteoblast Cultures
por: Mieczkowska, Aleksandra, et al.
Publicado: (2021)

Effects of PPARD gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus
por: Song, Jinfang, et al.
Publicado: (2022)

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
por: Dawson, Alison J., et al.
Publicado: (2019)

Exenatide Attenuates Non-Alcoholic Steatohepatitis by Inhibiting the Pyroptosis Signaling Pathway
por: Liu, Yu, et al.
Publicado: (2021)

Exenatide improves hepatocyte insulin resistance induced by different regional adipose tissue
por: Bai, Chuanmin, et al.
Publicado: (2022)

The anabolic action of intermittent parathyroid hormone on cortical bone depends partly on its ability to induce nitric oxide‐mediated vasorelaxation in BALB/c mice
por: Gohin, S, et al.
Publicado: (2016)

Exenatide once weekly for the treatment of type 2 diabetes: effectiveness and tolerability in patient subpopulations
por: Pencek, R, et al.
Publicado: (2012)

Exenatide Protects Against Cardiac Dysfunction by Attenuating Oxidative Stress in the Diabetic Mouse Heart
por: Ding, Wei, et al.
Publicado: (2019)

The Changes of Lipidomic Profiles Reveal Therapeutic Effects of Exenatide in Patients With Type 2 Diabetes
por: Zhang, Lin, et al.
Publicado: (2022)

Exenatide Attenuates Obesity-Induced Mitochondrial Dysfunction by Activating SIRT1 in Renal Tubular Cells
por: Wang, Yao, et al.
Publicado: (2021)

Inherited Real Risk of Type 2 Diabetes Mellitus: bedside diagnosis, pathophysiology and primary prevention
por: Stagnaro, Sergio, et al.
Publicado: (2013)

Brain Activation in Response to Low-Calorie Food Pictures: An Explorative Analysis of a Randomized Trial With Dapagliflozin and Exenatide
por: van Ruiten, Charlotte C., et al.
Publicado: (2022)

Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control
por: Stenlid, Rasmus, et al.
Publicado: (2023)

Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: clinical studies and practical approaches to therapy
por: Tobin, G S, et al.
Publicado: (2012)

Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women
por: Rodgers, Megan, et al.
Publicado: (2021)

Exenatide Use in the Management of Type 2 Diabetes Mellitus
por: Kyriacou, Angelos, et al.
Publicado: (2010)

Efficacy and safety of exenatide once‐weekly vs exenatide twice‐daily in Asian patients with type 2 diabetes mellitus
por: Ji, Linong, et al.
Publicado: (2013)

Inherited Thyroid Tumors With Oncocytic Change
por: Correia, Marcelo, et al.
Publicado: (2021)

Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis
por: Robinson, Louise E, et al.
Publicado: (2013)

Use of gonadotropin-releasing hormone (GnRH) agonist trigger in fertility preservation for patients with inherited genetic disorders
por: Merkison, Jamie, et al.
Publicado: (2022)

Vascular Calcification and Inherited Real Risk of Lithiasis
por: Stagnaro, Sergio, et al.
Publicado: (2012)

Not Enough Fat: Mouse Models of Inherited Lipodystrophy
por: Le Lay, Soazig, et al.
Publicado: (2022)

Epigenetic Transgenerational Inheritance of the Effects of Obesogen Exposure
por: Mohajer, Nicole, et al.
Publicado: (2021)

Isolation and in vitro characterization of murine young-adult long bone skeletal progenitors
por: Loopmans, Shauni, et al.
Publicado: (2022)

A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol
por: Brown, Emily, et al.
Publicado: (2021)

Genetics and Epigenetics: New Insight on Gestational Diabetes Mellitus
por: Dalfrà, Maria Grazia, et al.
Publicado: (2020)

Transgenerational Inheritance of Reproductive and Metabolic Phenotypes in PCOS Rats
por: Zhang, Hao-Lin, et al.
Publicado: (2020)

Inherited destiny? Genetics and gestational diabetes mellitus
por: Watanabe, Richard M
Publicado: (2011)

Genetic Susceptibility to Gestational Diabetes Mellitus in a Chinese Population
por: Cao, Minkai, et al.
Publicado: (2020)

The Potential Synergic Effect of a Complex Pattern of Multiple Inherited Genetic Variants as a Pathogenic Factor for Ovarian Dysgenesis: A Case Report
por: Cattoni, Alessandro, et al.
Publicado: (2020)

Hypogonadism, Type-2 Diabetes Mellitus, and Bone Health: A Narrative Review
por: Russo, Vittoria, et al.
Publicado: (2021)

The Emerging Role of Bone-Derived Hormones in Diabetes Mellitus and Diabetic Kidney Disease
por: Li, Yixuan, et al.
Publicado: (2022)

Prolactin is associated with bone mineral density in subjects with type 2 diabetes mellitus
por: Chen, Jia, et al.
Publicado: (2022)

Perirenalfat thickness is associated with bone turnover markers and bone mineral density in postmenopausal women with type 2 diabetes mellitus
por: Wang, Wei, et al.
Publicado: (2022)

The Genetic Architecture of High Bone Mass
por: Gregson, Celia L., et al.
Publicado: (2020)

The effects of exenatide and insulin glargine treatments on bone turnover markers and bone mineral density in postmenopausal patients with type 2 diabetes mellitus
por: Akyay, Ozlem Zeynep, et al.
Publicado: (2023)

Fracture-induced pain-like behaviours in a femoral fracture mouse model
por: Magnusdottir, R., et al.
Publicado: (2021)

Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links
por: De Rosa, Salvatore, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_juknpihm5p3l6feoflqcje6l3o